Registry-listed formulations

Dexmethylphenidate Hydrochloride · chembl:CHEMBL904

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

3 source entries across 3 studies. This list may not include all unresolved or historical entries.

  • Focalin XRRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Focalin XRRegistry intervention

    Linked study entry; product equivalence not established

    View study and source
  • Dexmethylphenidate HCl extended-release capsulesRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)

Phase Distribution

Phase 1
2
40%
Phase 3
3
60%

Phase Distribution

2

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 3Large-scale testing
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (40.0%)
Phase 33 (60.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions

NCT00829673
completedphase_1

Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions

NCT00829712
completedphase_3

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

NCT00141050
completedphase_3

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

NCT00141063
completedphase_3

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

NCT00301236

Clinical Trials (5)

Showing 5 of 5 trials
NCT00829673Phase 1

Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting Conditions

Completed
NCT00829712Phase 1

Dexmethylphenidate Hydrochloride Tablets Under Fasting Conditions

Completed
NCT00141050Phase 3

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

Completed
NCT00141063Phase 3

Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD

Completed
NCT00301236Phase 3

Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Completed

All 5 trials loaded

Drug Details

Intervention Type
Drug
Molecule Type
Small molecule
Total Trials
5

External References

ChEMBL
CHEMBL904

Names & Codes

Trade Names

focalin